Feb 09, 2022 / 02:00PM GMT
Anders Göransson - Bactiguard Holding AB(publ)-CEO
And thank you, everybody, for joining the call today, in which we will share some very exciting news and forward-looking thinking from our side.
Before we start, I want to inform you that a correction to our quarter-four press release. As we wanted you to have all relevant information at your hand, when we announced the Zimmer Biomet agreement last night, we accelerated our quarterly release, and we released it already last night. However, due to human factor, we released some incorrect numbers relating to the cash flow from operating activities.
We have, therefore, just released the corrected version, both in English and Swedish. Furthermore, this morning, it was noticed that the Swedish version still included some internal working comments that had been fully integrated in the report. Of course, this is not something we're proud of, and we're very sorry for this. And we are revising our processes to increase the quality, going forward.
If we go to page 2 and the more
Q4 2021 Bactiguard Holding AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
